5AM Solutions and LABVANTAGE Announce Partnership
News Feb 10, 2013
5AM announced that it is partnering with LABVANTAGE Solutions, an innovative provider of enterprise laboratory informatics software. 5AM will work closely with LABVANTAGE to provide consulting and implementation services in order to support current and future LABVANTAGE customers in government organizations, commercial organizations, and academic institutions.
The partnership will initially focus on meeting increasing customer demand for training, implementation, biobanking best practices, and data standardization. 5AM’s track record of integration and implementation expertise in the domains where biospecimens play a fundamental role combined with LABVANTAGE software will provide customers the ability to fully exercise the utility of the world’s leading LIMS software faster.
“We have admired each others’ progress for years and have discovered how we can add value together,” said Erica Marrari, Biospecimen Practice Lead at 5AM Solutions. “Doing what we each do best will allow us to serve the growing market need, delivering optimal value to customers who are at the core of translating science into medical benefit.”
“As we continue to experience significant growth in the Life Science LIMS and Biobanking space, we felt it was very important for us to expand and enhance our implementation capabilities by partnering with an organization that can offer strong domain expertise and proven best practices capabilities,” said Jerry Hacker, Sr. VP of Worldwide Sales at LABVANTAGE. “We are excited about this partnership and look forward to serving our customers in a manner that meets or exceeds their expectations.”
Scientists at Tokyo Tech, Ricoh co. and The National Institute of Advanced Industrial Science and Technology have developed an ultra-low-power atomic clock (ULPAC) for small satellites to enable future communication systems beyond 5G. The proposed device outperforms the current industry standards in various benchmarks, such as size, stability, and power consumption.
With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.READ MORE